Evidence map›Paper›PMID 33302413›Full record

ArticleNanomaterials (Basel, Switzerland)2020

The Impact of Polymer Size and Cleavability on the Intravenous Pharmacokinetics of PEG-Based Hyperbranched Polymers in Rats.

Nirmal Marasini, Changkui Fu, Nicholas L Fletcher, Christopher Subasic, Gerald Er, Karine Mardon, Kristofer J Thurecht, Andrew K Whittaker, Lisa M Kaminskas

Open access · goldAbstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Biomimetic Construction of Artificial Selenoenzymes.Biomimetics (Basel, Switzerland) · 2023
    Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Nirmal MarasiniSchool of Biomedical Sciences, The University of Queensland, St Lucia 4072, Queensland, Australia.ORCID 0000-0002-1958-2050
Changkui FuAustralian Institute for Bioengineering and Nanotechnology, The University of Queensland, St Lucia 4072, Queensland, Australia.
Nicholas L FletcherAustralian Institute for Bioengineering and Nanotechnology, The University of Queensland, St Lucia 4072, Queensland, Australia.ORCID 0000-0002-2993-833X
Christopher SubasicSchool of Biomedical Sciences, The University of Queensland, St Lucia 4072, Queensland, Australia.
Gerald ErAustralian Institute for Bioengineering and Nanotechnology, The University of Queensland, St Lucia 4072, Queensland, Australia.ORCID 0000-0002-7268-6553
Karine MardonCentre for Advance Imaging, The University of Queensland, St Lucia 4072, Queensland, Australia.
Kristofer J ThurechtAustralian Institute for Bioengineering and Nanotechnology, The University of Queensland, St Lucia 4072, Queensland, Australia.ORCID 0000-0002-4100-3131
Andrew K WhittakerAustralian Institute for Bioengineering and Nanotechnology, The University of Queensland, St Lucia 4072, Queensland, Australia.
Lisa M KaminskasSchool of Biomedical Sciences, The University of Queensland, St Lucia 4072, Queensland, Australia.
The University of Queensland · AU

Funding

The University of Queensland, internal support fund .
6 · The paper itself

Abstract

A better understanding of the impact of molecular size and linkers is important for PEG-based hyperbranched polymers (HBPs) intended as tailored drug delivery vehicles. This study aimed to evaluate the effects of crosslinker chemistry (cleavable disulphide versus non-cleavable ethylene glycol methacrylate (EGDMA) linkers) and molecular weight within the expected size range for efficient renal elimination (22 vs. 48 kDa) on the intravenous pharmacokinetic and biodistribution properties of

Indexed as

biodistributionhyperbranched polymernanomaterialsnanomedicinenanoparticlespharmacokineticspoly (ethylene glycol)

Identifiers

PMID33302413
PMCPMC7762536
OpenAlexW3111382208

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.